Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Radiation Oncology
•
Myelodysplastic Syndromes
•
Hematology
What are your current recommendations for treatment of symptomatic splenomegaly in the setting of myelofibrosis when splenectomy is not an option?
Is there a preferred low dose splenic irradiation regimine?
Answer from: Radiation Oncologist at Academic Institution
I use low dose, typically 50cGy per fraction for 4-6 fractions, done in 2 fractions per week; need to check platelets each week during course.
Sign in or Register to read more
881
Related Questions
How do you treat a stage IE DLBCL of the breast?
How soon after CAR T-cell therapy can salvage radiation be delivered?
What hemoglobin level prompts you to start erythropoietin in a patient with low-risk MDS?
What is your approach to cancer patients who inquire about alternative or complementary treatments?
Is there an advantage to early therapy with hypomethylating agents for high/very high risk patients with MDS who are not transplant candidates and have only mild cytopenias?
How will you manage a patient with symptomatic secondary CNS involvement from DLBCL not eligible for HD-MTX?
Do you recommend postoperative radiation for spinal cord compression DLBCL?
Are you now using luspatercept as your first choice for anemia management in patients with low-risk MDS otherwise appropriate for EPO initiation, regardless of presence of SF3B1 or ringed sideroblasts?
How do you approach a patient with CMML requiring platelet transfusions?
Is there an optimal salvage radiation dose for relapsed post-CART disease?